Real-time enrollment status for this epilepsy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:52 PM UTC
| NCT Number | NCT05135091 |
| Recruiting Status | Recruiting |
| Condition | Epilepsy |
| Phase | PHASE3 |
| Target Enrollment | 88 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Neurona Therapeutics |
| Last Updated on CT.gov | June 9, 2026 (Jun 9, 2026) |
As of July 17, 2026: Clinical trial NCT05135091 is currently recruiting participants. This phase3 study for epilepsy is actively seeking new participants at 35 locations across the United States. The study is sponsored by Neurona Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05135091 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05135091 was last updated Jun 9, 2026 (June 9, 2026). HelloStudys verifies this status automatically.